Vanguard Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Sell |
|
|||||
|
2025
Q1 | $3.31M | Buy |
|
|||||
|
2024
Q4 | $3.06M | Sell |
|
|||||
|
2024
Q3 | $10.4M | Buy |
|
|||||
|
2024
Q2 | $12.8M | Sell |
|
|||||
|
2024
Q1 | $22.1M | Sell |
|
|||||
|
2023
Q4 | $10.1M | Sell |
|
|||||
|
2023
Q3 | $7.81M | Buy |
|
|||||
|
2023
Q2 | $8.96M | Buy |
|
|||||
|
2023
Q1 | $15M | Buy |
|
|||||
|
2022
Q4 | $26.6M | Buy |
|
|||||
|
2022
Q3 | $26.5M | Buy |
|
|||||
|
2022
Q2 | $23.1M | Buy |
|
|||||
|
2022
Q1 | $40.4M | Buy |
|
|||||
|
2021
Q4 | $55.1M | Buy |
|
|||||
|
2021
Q3 | $78.4M | Buy |
|
|||||
|
2021
Q2 | $101M | Sell |
|
|||||
|
2021
Q1 | $107M | Buy |
|
|||||
|
2020
Q4 | $81.3M | Sell |
|
|||||
|
2020
Q3 | $108M | Sell |
|
|||||
|
2020
Q2 | $258M | Buy |
|
|||||
|
2020
Q1 | $41.6M | Buy |
|
|||||
|
2019
Q4 | $16.7M | Sell |
|
|||||
|
2019
Q3 | $10.5M | Buy |
|
|||||
|
2019
Q2 | $14.3M | Buy |
|
|||||
|
2019
Q1 | $18M | Buy |
|
|||||
|
2018
Q4 | $18.2M | Buy |
|
|||||
|
2018
Q3 | $23.6M | Buy |
|
|||||
|
2018
Q2 | $15.9M | Buy |
|
|||||
|
2018
Q1 | $18.4M | Buy |
|
|||||
|
2017
Q4 | $16M | Buy |
|
|||||
|
2017
Q3 | $24M | Buy |
|
|||||
|
2017
Q2 | $25.3M | Buy |
|
|||||
|
2017
Q1 | $20.5M | Buy |
|
|||||
|
2016
Q4 | $19.9M | Buy |
|
|||||
|
2016
Q3 | $26.2M | Buy |
|
|||||
|
2016
Q2 | $25.8M | Buy |
|
|||||
|
2016
Q1 | $23.3M | Buy |
|
|||||
|
2015
Q4 | $16.7M | Buy |
|
|||||
|
2015
Q3 | $14.1M | Buy |
|
|||||
|
2015
Q2 | $18.7M | Buy |
|
|||||
|
2015
Q1 | $16.5M | Buy |
|
|||||
|
2014
Q4 | $17.7M | Buy |
|
|||||
|
2014
Q3 | $17.2M | Buy |
|
|||||
|
2014
Q2 | $18.1M | Buy |
|
|||||
|
2014
Q1 | $18.9M | Buy |
|
|||||
|
2013
Q4 | $11.7M | Buy |
|
|||||
|
2013
Q3 | $7.62M | Buy |
|
|||||
|
2013
Q2 | $2.76M | Buy |
|